Guggenheim Upgrades DexCom to Buy, Announces $580 Price Target

Guggenheim analyst Chris Pasquale upgrades DexCom (NASDAQ:DXCM) from Neutral to Buy and announces $580 price target.

Guggenheim analyst Chris Pasquale upgrades DexCom (NASDAQ:DXCM) from Neutral to Buy and announces $580 price target.

Total
0
Shares
Related Posts